DK1292586T3 - Fremgangsmåde til fremstilling af pyrazolopyrimidinoner - Google Patents

Fremgangsmåde til fremstilling af pyrazolopyrimidinoner

Info

Publication number: DK1292586T3
Authority: DK; Denmark
Prior art keywords: pyrazolopyrimidinones; preparation
Prior art date: 2000-06-22

Application number

DK01936737T

Other languages

English (en)

Inventor

Peter James Dunn

Catherine Dunne

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-22

Filing date

2001-06-11

Publication date

2004-08-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26244540&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1292586(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-06-22 Priority claimed from GB0015472A external-priority patent/GB0015472D0/en

2001-03-09 Priority claimed from GB0105857A external-priority patent/GB0105857D0/en

2001-06-11 Application filed by Pfizer filed Critical Pfizer

2004-08-30 Application granted granted Critical

2004-08-30 Publication of DK1292586T3 publication Critical patent/DK1292586T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DK01936737T 2000-06-22 2001-06-11 Fremgangsmåde til fremstilling af pyrazolopyrimidinoner DK1292586T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0015472A GB0015472D0 (en)	2000-06-22	2000-06-22	Novel process for the preparation of pyrazolopyrimidinones
GB0105857A GB0105857D0 (en)	2001-03-09	2001-03-09	Novel process for the preparation of pyrazolopyrimidinones

Publications (1)

Publication Number	Publication Date
DK1292586T3 true DK1292586T3 (da)	2004-08-30

Family

ID=26244540

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01936737T DK1292586T3 (da)	2000-06-22	2001-06-11	Fremgangsmåde til fremstilling af pyrazolopyrimidinoner

Country Status (28)

Country	Link
EP (1)	EP1292586B1 (da)
JP (1)	JP2004501142A (da)
KR (1)	KR100525698B1 (da)
CN (1)	CN100338047C (da)
AP (1)	AP2001002194A0 (da)
AR (1)	AR028740A1 (da)
AT (1)	ATE272626T1 (da)
AU (2)	AU6259701A (da)
BR (1)	BR0111581A (da)
CA (1)	CA2411961C (da)
CZ (1)	CZ20024176A3 (da)
DE (1)	DE60104691T2 (da)
DK (1)	DK1292586T3 (da)
DO (1)	DOP2001000190A (da)
ES (1)	ES2223863T3 (da)
HU (1)	HUP0301183A3 (da)
IL (1)	IL153532A0 (da)
MX (1)	MXPA02012884A (da)
MY (1)	MY124903A (da)
PA (1)	PA8519801A1 (da)
PE (1)	PE20020105A1 (da)
PL (1)	PL359651A1 (da)
PT (1)	PT1292586E (da)
SV (1)	SV2002000503A (da)
TN (1)	TNSN01093A1 (da)
TR (1)	TR200401983T4 (da)
WO (1)	WO2001098284A1 (da)
YU (1)	YU93902A (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2310144B1 (es) *	2007-06-15	2010-01-12	Galenicum Health, S.L.	Intermedios para la preparacion de un inhibidor de la fosfodiesterasa tipo 5.
EP2228370B1 (en) *	2007-12-28	2012-05-23	Topharman Shanghai Co., Ltd.	N-{1-[3-(2-ethoxy-5-(4-ethylpiperazinyl)benzenesulfonyl)-4,5-dihydro-5-oxo-1,2,4-triazin-6-yl]ethyl}butyramide, the preparation method and use thereof
CN101747282A (zh) *	2008-12-10	2010-06-23	上海特化医药科技有限公司	一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途
WO2011016016A1 (en)	2009-08-07	2011-02-10	Ranbaxy Laboratories Limited	Processes for the preparation of vardenafil
JP2013517281A (ja) *	2010-01-13	2013-05-16	テンペロ、ファーマシューティカルズ、インコーポレイテッド	化合物及び方法
MX2010006227A (es)	2010-06-07	2011-12-14	World Trade Imp Exp Wtie Ag	Nuevos derivados 1,4-diazepanos, inhibidores de pde-5.
FR2970967B1 (fr)	2011-01-27	2013-02-15	Pf Medicament	Derives de type azaindazole ou diazaindazole comme medicament
EP2689778A1 (en)	2012-07-27	2014-01-29	Pierre Fabre Medicament	Derivatives of azaindoles or diazaindoles for treating pain
EP2689779A1 (en)	2012-07-27	2014-01-29	Pierre Fabre Medicament	Derivatives of azaindazole or diazaindazole type for treating a cancer overexpressing trk
PL3529246T3 (pl) *	2016-10-24	2024-03-25	Fmc Corporation	Oksadiazole o działaniu grzybobójczym
JP2022501410A (ja) *	2018-10-01	2022-01-06	ピーアイインダストリーズリミテッドPi Industries Ltd	新規なオキサジアゾール

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9822238D0 (en) *	1998-10-12	1998-12-09	Pfizer Ltd	Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof
EP1002798A1 (en) *	1998-11-20	2000-05-24	Orchid Chemicals & Pharmaceuticals Ltd.	An improved process for preparing a therapeutically active pyrazolopyrimidinone derivative

2001
- 2001-06-11 PL PL01359651A patent/PL359651A1/xx not_active Application Discontinuation
- 2001-06-11 AP APAP/P/2001/002194A patent/AP2001002194A0/en unknown
- 2001-06-11 BR BR0111581-2A patent/BR0111581A/pt not_active IP Right Cessation
- 2001-06-11 ES ES01936737T patent/ES2223863T3/es not_active Expired - Lifetime
- 2001-06-11 DE DE2001604691 patent/DE60104691T2/de not_active Expired - Fee Related
- 2001-06-11 AU AU6259701A patent/AU6259701A/xx active Pending
- 2001-06-11 DK DK01936737T patent/DK1292586T3/da active
- 2001-06-11 CA CA002411961A patent/CA2411961C/en not_active Expired - Fee Related
- 2001-06-11 CZ CZ20024176A patent/CZ20024176A3/cs unknown
- 2001-06-11 MX MXPA02012884A patent/MXPA02012884A/es active IP Right Grant
- 2001-06-11 TR TR2004/01983T patent/TR200401983T4/xx unknown
- 2001-06-11 HU HU0301183A patent/HUP0301183A3/hu unknown
- 2001-06-11 WO PCT/IB2001/001050 patent/WO2001098284A1/en not_active Ceased
- 2001-06-11 JP JP2002504240A patent/JP2004501142A/ja active Pending
- 2001-06-11 EP EP01936737A patent/EP1292586B1/en not_active Expired - Lifetime
- 2001-06-11 IL IL15353201A patent/IL153532A0/xx unknown
- 2001-06-11 YU YU93902A patent/YU93902A/sh unknown
- 2001-06-11 AU AU2001262597A patent/AU2001262597B2/en not_active Ceased
- 2001-06-11 KR KR10-2002-7017548A patent/KR100525698B1/ko not_active Expired - Fee Related
- 2001-06-11 PT PT01936737T patent/PT1292586E/pt unknown
- 2001-06-11 AT AT01936737T patent/ATE272626T1/de not_active IP Right Cessation
- 2001-06-11 CN CNB018114814A patent/CN100338047C/zh not_active Expired - Fee Related
- 2001-06-15 DO DO2001000190A patent/DOP2001000190A/es unknown
- 2001-06-15 PA PA20018519801A patent/PA8519801A1/es unknown
- 2001-06-19 MY MYPI20012889 patent/MY124903A/en unknown
- 2001-06-20 AR ARP010102935A patent/AR028740A1/es active IP Right Grant
- 2001-06-20 PE PE2001000599A patent/PE20020105A1/es not_active Application Discontinuation
- 2001-06-21 SV SV2001000503A patent/SV2002000503A/es not_active Application Discontinuation
- 2001-06-21 TN TNTNSN01093A patent/TNSN01093A1/fr unknown

Also Published As

Publication number	Publication date
CA2411961C (en)	2007-02-06
ES2223863T3 (es)	2005-03-01
MXPA02012884A (es)	2003-05-14
CA2411961A1 (en)	2001-12-27
PE20020105A1 (es)	2002-02-21
KR20030031912A (ko)	2003-04-23
TR200401983T4 (tr)	2004-09-21
AP2001002194A0 (en)	2002-12-21
CN1437589A (zh)	2003-08-20
SV2002000503A (es)	2002-07-03
DE60104691T2 (de)	2005-01-13
HK1054926A1 (en)	2003-12-19
DE60104691D1 (de)	2004-09-09
EP1292586A1 (en)	2003-03-19
EP1292586B1 (en)	2004-08-04
CN100338047C (zh)	2007-09-19
BR0111581A (pt)	2003-03-25
PT1292586E (pt)	2004-11-30
IL153532A0 (en)	2003-07-06
AU6259701A (en)	2002-01-02
JP2004501142A (ja)	2004-01-15
YU93902A (sh)	2005-11-28
HUP0301183A2 (hu)	2003-08-28
ATE272626T1 (de)	2004-08-15
MY124903A (en)	2006-07-31
HUP0301183A3 (en)	2006-02-28
WO2001098284A1 (en)	2001-12-27
AR028740A1 (es)	2003-05-21
KR100525698B1 (ko)	2005-11-03
AU2001262597B2 (en)	2005-10-20
TNSN01093A1 (fr)	2005-11-10
DOP2001000190A (es)	2002-05-15
PL359651A1 (en)	2004-08-23
CZ20024176A3 (cs)	2004-01-14
PA8519801A1 (es)	2002-04-25

Publication	Publication Date	Title
DK1296935T3 (da)	2009-06-22	Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1296656T3 (da)	2006-11-27	Fremgangsmåde til fremstilling af et præparat
DK1277722T3 (da)	2005-04-25	Fremgangsmåde til fremstilling af methanol
CY2007029I2 (el)	2009-11-04	Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
DK1309545T3 (da)	2007-10-29	Fremgangsmåde til fremstilling af alkylarylsulfonater
DK1326585T3 (da)	2006-05-22	Fremgangsmåde til fremstilling af pulverformuleringer
DK1309582T3 (da)	2005-03-14	Fremgangsmåde til fremstilling af citalopram
DK1259512T3 (da)	2003-12-29	Pteridinforbindelser til behandling af psoreasis
DK1380121T3 (da)	2007-12-27	Fremgangsmåde til fremstilling af oxazolidinoner
DK1345939T3 (da)	2006-09-25	Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner
DK1263717T3 (da)	2007-07-30	Fremgangsmåde til fremstilling af methionin
DK1326836T3 (da)	2004-06-01	Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1292586T3 (da)	2004-08-30	Fremgangsmåde til fremstilling af pyrazolopyrimidinoner
DK1187833T3 (da)	2007-10-08	Fremgangsmåde til fremstilling af thiamethoxam
DK1456229T3 (da)	2010-01-04	Fremgangsmåe til fremstilling af echinocandin-derivater
DK1296970T3 (da)	2008-07-14	Fremgangsmåde til fremstilling af citalopram
NO20030515D0 (no)	2003-02-03	Fremgangsmåte for fremstilling av dinapsolin
DK1268482T3 (da)	2003-12-22	Pyranoindoler til behandling af glaukom
DK1203000T3 (da)	2003-06-02	Fremgangsmåde til fremstilling af phosphonomethylglycin
DK1299181T3 (da)	2005-04-25	Fremgangsmåde til fremstilling af formaldehyd
DK1294694T3 (da)	2004-12-27	Fremgangsmåde til fremstilling af quinolinderivater
DK1165483T3 (da)	2004-07-05	Fremgangsmåde til fremstilling af carbonylfluorid
DK1309607T3 (da)	2005-01-17	Fremgangsmåde til fremstilling af LHRH-antagonister
DK1272486T3 (da)	2004-12-06	Fremgangsmåde til fremstilling af 7-(pyrazol-3-yl)benzoxazoler
DK1240173T3 (da)	2003-09-15	Fremgangsmåde til fremstilling af N-phosphonomethylglycin